<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/63463" />
  <subtitle />
  <id>http://dspace.bsuedu.ru/handle/123456789/63463</id>
  <updated>2026-04-07T18:42:33Z</updated>
  <dc:date>2026-04-07T18:42:33Z</dc:date>
  <entry>
    <title>Curcumin ameliorates oxaliplatin-induced allodynia response and melanocortin downregulation in the spinal cord</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/63925" />
    <author>
      <name>Alma Nuril Aliyah</name>
    </author>
    <author>
      <name>Luke Wongso</name>
    </author>
    <author>
      <name>Diah Ayu Wakita Trimanda</name>
    </author>
    <author>
      <name>Risda Maulida</name>
    </author>
    <author>
      <name>I Nengah Budi Sumartha</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/63925</id>
    <updated>2024-11-13T00:08:35Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Curcumin ameliorates oxaliplatin-induced allodynia response and melanocortin downregulation in the spinal cord
Authors: Alma Nuril Aliyah; Luke Wongso; Diah Ayu Wakita Trimanda; Risda Maulida; I Nengah Budi Sumartha
Abstract: This study investigated the effect of curcumin on CIPN conditions. In addition, we further elaborated to measure the involvement of spinal melanocortin and the TRPA1 system</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Chemoproteomic analysis of the promising candidate molecule of the indole derivative with lab code SV-1010 and other non-steroidal antiinflammatory drugs</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/63924" />
    <author>
      <name>Galenko-Yaroshevsky, P. A.</name>
    </author>
    <author>
      <name>Torshin, I. Yu.</name>
    </author>
    <author>
      <name>Gromov, A. N.</name>
    </author>
    <author>
      <name>Reyer, I. A.</name>
    </author>
    <author>
      <name>Gromova, O. A.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/63924</id>
    <updated>2024-11-13T00:10:30Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Chemoproteomic analysis of the promising candidate molecule of the indole derivative with lab code SV-1010 and other non-steroidal antiinflammatory drugs
Authors: Galenko-Yaroshevsky, P. A.; Torshin, I. Yu.; Gromov, A. N.; Reyer, I. A.; Gromova, O. A.
Abstract: The aim of the study was to evaluate the complex of differences between the promising candidate-molecule of indole derivative SV-1010 and the well-known NSAIDs</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Cytotoxic and cytostatic activity of five new imidazotetrazine derivatives on breast cancer cell cultures MDAMB231, BT474, and MCF-7</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/63923" />
    <author>
      <name>Ahmed Hamid Al-Humairi</name>
    </author>
    <author>
      <name>Sitnikova, S. E.</name>
    </author>
    <author>
      <name>Novochadov, V. V.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/63923</id>
    <updated>2024-11-13T00:08:36Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Cytotoxic and cytostatic activity of five new imidazotetrazine derivatives on breast cancer cell cultures MDAMB231, BT474, and MCF-7
Authors: Ahmed Hamid Al-Humairi; Sitnikova, S. E.; Novochadov, V. V.
Abstract: The work presents the results of the study of new imidazotetrazine derivatives to establish the possibility of using them as anticancer agents, including for chemotherapy of metastatic breast cancer</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Ascorbic acid-containing compound efficacy in ischemic brain damage</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/63922" />
    <author>
      <name>Termulaeva, R. M.</name>
    </author>
    <author>
      <name>Belanov, K. V.</name>
    </author>
    <author>
      <name>Bunyatyan, N. D.</name>
    </author>
    <author>
      <name>Pirozhkov, A. S.</name>
    </author>
    <author>
      <name>Timoshkin, D. E.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/63922</id>
    <updated>2024-11-13T00:08:26Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Ascorbic acid-containing compound efficacy in ischemic brain damage
Authors: Termulaeva, R. M.; Belanov, K. V.; Bunyatyan, N. D.; Pirozhkov, A. S.; Timoshkin, D. E.
Abstract: The aim: to assess anti-ischemic activity of 3-hydroxypyridine ascorbate in the in vitro and in vivo models of brain cell and tissue response to ischemia and reoxygenation</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

